Natural Products Pre-Registration Test
For more information or to access the Directive, please CLICK HERE
Document attached
Official Malaysian Government Website
Newsroom
868 items
Announcements, product safety communications and regulatory updates.
For more information or to access the Directive, please CLICK HERE
Document attached
Perkara Tarikh Pembatalan Arahan Bilangan 26 Tahun 2017 : Direktif Pindaan Had Harian Pengambilan Menthol Dalam Persediaan Oral Rujukan (dibaca bersama) : Arahan Bilangan 26 Tahun 2017…
Document attached
Document attached
Direktif Tarikh Direktif Berkenaan Keperluan Mendaftar Penyelidikan Klinikal Sukarelawan Sihat Dengan National Healthy Research Volunteer Register (NHRVR) Kepada Sponsor/Pemohon/Penyelidik Yang…
Document attached
Dear healthcare professionals, Reports from healthcare professionals about COVID-19 vaccines help us monitor their safety and detect new information.#ReportSideEffectsIf you see or are told about a…
Document attached
Direktif Tarikh Direktif Berkenaan Keperluan Mendaftar Penyelidikan Klinikal Sukarelawan Sihat Dengan National Healthy Research Volunteer Register (NHRVR) Kepada Sponsor/Pemohon/Penyelidik Yang…
Document attached
Direktif Tarikh Direktif Berkenaan Keperluan Mendaftar Penyelidikan Klinikal Sukarelawan Sihat Dengan National Healthy Research Volunteer Register (NHRVR) Kepada Sponsor/Pemohon/Penyelidik Yang…
Document attached
Dear healthcare professionals, Do you suspect your patient may be experiencing a side effect after receiving a vaccine? By reporting suspected side effects to the National Pharmaceutical Regulatory…
Document attached
#MedSafetyWeek starts today! Post-market surveillance is an important and vital part of ensuring the safety of any healthcare product like a medicine or vaccine. Throughout the week we are…
Document attached
Document attached
Direktif Tarikh Direktif untuk semua produk yang mengandungi anastrozole: Pengemaskinian sisip bungkusan dan Risalah Maklumat Ubat untuk Pengguna (RiMUP) dengan maklumat keselamatan berkaitan risiko…
Document attached
Direktif Tarikh Direktif untuk semua produk yang mengandungi bortezomib: Pengemaskinian sisip bungkusan dengan maklumat keselamatan berkaitan risiko Guillain-Barré syndrome dan demyelinating…
Document attached
Direktif Tarikh Direktif untuk semua produk yang mengandungi mycophenolate (mycophenolate mofetil dan mycophenolic acid): Pengemaskinian sisip bungkusan dan Risalah Maklumat Ubat untuk Pengguna…
Document attached
Direktif Tarikh Direktif untuk semua produk yang mengandungi insulin (termasuk produk kombinasi): Pengemaskinian sisip bungkusan dan Risalah Maklumat Ubat untuk Pengguna (RiMUP) dengan maklumat…
Document attached
Overview Bortezomib is a reversible proteasome inhibitor, which is indicated for the treatment of multiple myeloma and mantle cell lymphoma by altering the regulatory proteins that control the…
UPDATE: 3 Jan 2021 @ 1.00 p.m. To all our valued QUEST 3+ users, Due to unforeseen circumstances, payment gateway error is currently under investigation. We apologize for the inconveniences caused…
Overview Non-Vitamin K antagonist Oral Anticoagulants (NOACs) are now increasingly used in patients with non-valvular atrial fibrillation and for the prevention/treatment of venous thromboembolism.1…
Dear Users, Please be informed that there will be changes in the Enquiry / Complaint Form, with enhanced categorization. This is to ensure all enquiries are attended to accordingly. There will be a…
Click Image for MORE INFORMATION
Document attached
Click Image for MORE INFORMATION.
Document attached
Document attached
To access guideline, CLICK HERE . To access directive, CLICK HERE .
Document attached
For More information, CLICK HERE
Document attached
Date / Day : 5-6 October 2021 / Tuesday & Wednesday Venue : Virtual (WebEx) Who should attend : Private Laboratories (Natural Product Testing) Objectives : 1. To promote awareness on quality control…
Document attached
Overview Sacubitril/valsartan is an angiotensin receptor-neprilysin inhibitor (ARNi), which is a combination of a neprilysin inhibitor (sacubitril) and an angiotensin II receptor blocker (ARB)…